Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies

Sevil Yasar, Jack Bergman

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

l-Deprenyl has dose-dependent amphetamine- and methamphetamine-like discriminative stimulus properties in rats and monkeys. However, these actions occur only at doses that are well above the clinically relevant dose range for l-deprenyl and are likely to reflect its metabolic conversion to amphetamine products. In view of its weak potency for producing amphetamine-like effects and their slow onset, it may not be surprising that l-deprenyl does not appear to have amphetamine-like abuse potential and has been used therapeutically in the treatment of Parkinson syndrome for more than 20 years with no reported instances of abuse.

Original languageEnglish (US)
Pages (from-to)768-773
Number of pages6
JournalClinical pharmacology and therapeutics
Volume56
Issue number6
StatePublished - Dec 1994

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies'. Together they form a unique fingerprint.

Cite this